Literature DB >> 11096594

Chronic Idiopathic Intestinal Pseudo-obstruction.

.   

Abstract

The definition of chronic idiopathic intestinal pseudo-obstruction (CIIP) is somewhat vague because it was based on clinical observations that preceded modern advances in the measurement of gut motility and neuromuscular integrity. Appropriate management of patients with CIIP requires an initial consideration, supported by pertinent diagnostic tests, of the tissue affected (muscle, nerves, both), extent and magnitude of gut propulsive failure, and extraintestinal disease.

Entities:  

Year:  2000        PMID: 11096594     DOI: 10.1007/s11938-000-0047-2

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  10 in total

Review 1.  Nutritional management of chronic intestinal pseudo-obstruction.

Authors:  J S Scolapio; A Ukleja; E P Bouras; M Romano
Journal:  J Clin Gastroenterol       Date:  1999-06       Impact factor: 3.062

2.  Intestinal pseudo-obstruction.

Authors:  H A DUDLEY; I S SINCLAIR; I F McLAREN; T J McNAIR; J E NEWSAM
Journal:  J R Coll Surg Edinb       Date:  1958-03

3.  Megaduodenum due to hollow visceral myopathy successfully managed by duodenoplasty and feeding jejunostomy.

Authors:  P I Mansell; R B Tattersall; M Balsitis; J Lowe; R C Spiller
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

4.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

5.  Small bowel resection for relief of chronic intestinal pseudo-obstruction.

Authors:  R F Noel; M D Schuffler; W S Helton
Journal:  Am J Gastroenterol       Date:  1995-07       Impact factor: 10.864

6.  Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.

Authors:  M Camilleri; M L Brown; J R Malagelada
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

7.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Authors:  G N Verne; E Y Eaker; E Hardy; C A Sninsky
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 8.  Clinical use of cisapride and its risk-benefit in paediatric patients.

Authors:  Y Vandenplas
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-10       Impact factor: 2.566

9.  Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.

Authors:  V Stanghellini; M Camilleri; J R Malagelada
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

10.  The surgeon's role in the treatment of chronic intestinal pseudoobstruction.

Authors:  M M Murr; M G Sarr; M Camilleri
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.